<DOC>
	<DOCNO>NCT02968420</DOCNO>
	<brief_summary>The overall aim study understand memory response HPV vaccination subject receive 2 versus 3 dos quadrivalent HPV vaccine . Although memory response detect shortly immunization , best approach measure long-lasting anamnestic response challenge booster dose year ( &gt; 5 ) original exposure .</brief_summary>
	<brief_title>Long Term Immune Memory Responses Human Papillomavirus ( HPV ) Vaccination Following 2 Verses 3 Doses Quadrivalent HPV Vaccine</brief_title>
	<detailed_description>This single center , interventional study evaluate long term memory response Q-HPV vaccination natural infection . Memory response assess measure seroprotection 8-10 year post Q-HPV vaccination challenge booster dose year original exposure measure long-lasting anamnestic response .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written inform consent provide participant . Participant investigator believe comply requirement protocol . General good health . Immunized QHPV vaccine age 913 16 26 year BCGov01 study BC provincial program . Participant child bear potential must willing ensure partner use effective contraception study . Examples effective method birth control include : Abstinence ( sexual activity ) Hormonal contraceptive include oral , injectable , implant &amp; skin patch Intrauterine device ( IUD ) Male partner sterilization Male condom combine vaginal spermicide ( foam , gel , film , cream suppository ) Male condom combine female diaphragm , whether without vaginal spermicide ( foam , gel , cream , suppository ) Adequate contraception apply participant sex partner , prefer usual lifestyle Received 3 dos QHPV vaccine Systemic hypersensitivity QHPV vaccine severe reaction previous dose QHPV vaccine . Receipt blood blood product within 3 month prior Visit 1 . Immune compromise result disease immunosuppressive systemic medication use within 3 month prior Visit 1 . Inadequate participant fluency English provide fully inform consent . Participant currently pregnant plan pregnancy course trial</criteria>
	<gender>Female</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>